Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
90 participants
INTERVENTIONAL
2010-03-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myo-inositol Plus Melatonin in Perimenopausal Women
NCT01325389
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
NCT06057896
Effects of the Concentrated Extract of Soy on Coagulation Factors After Menopause
NCT00925639
Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal Women
NCT00235924
Transdermal Testosterone Nanoemulsion in Women Libido
NCT02445716
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Myo-inositol is involved in several aspects of human reproduction. Elevated concentrations of myo-inositol in human follicular fluids appear to play a positive function in follicular maturity and provide a marker of good quality oocytes. Nevertheless its positive role in PCOS women is a consequence of a defect in the insulin signalling pathway (inositol-containing phosphoglycan mediators) that seems to be primarily implicated in the pathogenesis of insulin resistance
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
myo-inositol
30 subjects will take 2 tablets per day containing 2 grams of myo-inositol, for 6 months.
myo-inositol
30 subjects will take 2 tablets per day containing 2 grams of myo-inositol, for 6 months.
melatonin
30 subjects will take 1 tablet per day (at night-time) containing 3 grams of melatonin for 6 months
melatonin
30 subjects will take 1 tablet per day (at night-time) containing 3 grams of melatonin for 6 months
melatonin plus myo-inositol
30 subjects will take 2 grams per day of myo-inositol and 3 grams of melatonin at night-time for 6 months
melatonin plus myo-inositol
30 subjects will take 2 grams per day of myo-inositol and 3 grams of melatonin at night-time for 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
melatonin
30 subjects will take 1 tablet per day (at night-time) containing 3 grams of melatonin for 6 months
myo-inositol
30 subjects will take 2 tablets per day containing 2 grams of myo-inositol, for 6 months.
melatonin plus myo-inositol
30 subjects will take 2 grams per day of myo-inositol and 3 grams of melatonin at night-time for 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Messina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rosario D'anna
Myo-inositol and melatonin in menopausal transition.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rosario D'Anna, MD
Role: PRINCIPAL_INVESTIGATOR
University of Messina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Messina, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Myo-Mela-2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.